/
GRNA
$0.30-$0.00 (-0.03%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Price (6 mo)
Loading chart…
Change$-9.10
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
| Revenue | $3.0M | $962.0K | $0 | $6.4M |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $3.0M | $962.0K | $0 | $6.4M |
| Gross margin | 100.0% | 100.0% | — | 100.0% |
| R&D | $23.5M | $42.9M | $89.8M | $133.8M |
| Operating income | −$29.2M | −$52.3M | −$108.6M | −$163.9M |
| EBITDA | −$27.6M | −$50.4M | −$102.7M | −$154.0M |
| Net income | −$29.0M | −$54.3M | −$114.7M | −$167.1M |
| Net margin | -965.2% | -5642.3% | — | -2616.8% |
| EPS (diluted) | -0.30 | -0.56 | -0.93 | -1.27 |
Annual figures · source: Financial Modeling Prep
Peer comparison
Held by traders on TradeandTell
No one on the platform currently holds GRNA.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in GRNA as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded GRNA yet.
